20家园区药企跻身全国百强

Core Insights - The 7th China Pharmaceutical Industry Expo was held in Suzhou Industrial Park, showcasing the strength of domestic innovative pharmaceutical companies [1] - The "2025 China Innovative Pharmaceutical Company Ranking TOP101" list was released, highlighting 20 companies from the park, including Innovent Biologics, CStone Pharmaceuticals, and others [1] - The ranking evaluates companies based on market value, performance, R&D pipeline, commercialization, R&D investment, and incubation, reflecting the competitive landscape of China's innovative drug sector [1] Industry Overview - Since 2006, the Suzhou Industrial Park has focused on the biopharmaceutical and health industry, concentrating on innovative drugs, high-end medical devices, and health sectors [1] - The park has attracted over 2,000 related enterprises and achieved an output value of 165.5 billion yuan last year [1] - In the innovative drug sector, six first-class innovative drugs have been approved for market this year, accounting for approximately 20% of the national total for the same period, demonstrating the park's leading position in China's biopharmaceutical field [1] Future Plans - The park aims to foster a favorable environment for technological, industrial, and collaborative innovation, increasing support for the industry to promote the growth of more innovative companies [1] - The goal is to establish an internationally leading source of biopharmaceutical innovation and a world-class core area for the biopharmaceutical industry [1]